Novo Nordisk 20. Apr. 2026 Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Novo Nordisk 20. Apr. 2026 Novo Nordisk Details Progress of DKK 15 Billion Share Buyback Programme - TipRanks
Novo Nordisk 20. Apr. 2026 Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win - Fierce Biotech
Novo Nordisk 20. Apr. 2026 Novo posts trial win for sickle cell disease drug (NVO:NYSE) - Seeking Alpha
Novo Nordisk 17. Apr. 2026 Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. - Investor's Business Daily
FierceBiotech 1. Apr. 2026 KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
FierceBiotech 25. März 2026 Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
FierceBiotech 12. März 2026 Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
Endpoints News 12. März 2026 Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank
Endpoints News 27. Feb. 2026 Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future
FierceBiotech 25. Feb. 2026 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess